Thesis Capital Announces 2026 Entrepreneur-in-Residence (EIR) Cohort Fully Allocated; Searcher-in-Residence (SIR) Program Now Primary In-Residence Pathway
February 24, 2026 — Thesis Capital Partners (“Thesis”) today announced that its 2026 Entrepreneur-in-Residence (EIR) cohort is fully allocated, following strong interest from experienced operators seeking to acquire and scale lower middle market businesses in partnership with the firm.
The EIR pathway is designed for seasoned executives pursuing platform acquisitions generating $4+ million in EBITDA within the lower middle market. These transactions are typically structured with institutional capital and focused on building durable, scalable platforms positioned for long-term value creation through disciplined operations, strategic growth initiatives, and thoughtful capital allocation.
With the 2026 EIR cohort fully committed, Thesis will continue deploying capital alongside its current EIR partners while evaluating future cohort opportunities.
The firm’s Searcher-in-Residence (SIR) program now represents the primary pathway for operators seeking to build in-residence with Thesis.
Two Distinct Pathways. One Investment Philosophy.
Thesis structures its in-residence partnerships across two tracks, aligned by a shared commitment to long-term ownership and operational excellence.
Entrepreneur-in-Residence (EIR)
-Platform acquisitions of $4M+ EBITDA
-Institutional capital structures
-Lower middle market focus
-Emphasis on scalable platform development
-Long-term value creation mandate
The 2026 EIR cohort is fully allocated.
Searcher-in-Residence (SIR)
-Target acquisitions in the $1–4M EBITDA range
-Operator-led majority ownership model
-Structured governance and underwriting support
-Designed for disciplined lower middle market acquisitions with durable cash flow characteristics
With EIR capacity allocated for 2026, SIR now serves as the primary entry point for operators seeking to partner with Thesis on acquisitions.
Institutional Support for Operator-Led Acquisitions
The SIR program is designed to materially increase execution probability for operators pursuing lower middle market transactions.
In addition to long-term capital partnership, SIR operators receive:
-Institutional underwriting and transaction guidance
-Structured governance framework
-Access to vetted diligence providers
-Established capital relationships
-Post-close advisory and operational support
-Top-tier sourcing infrastructure and proprietary dealflow
Thesis operates as a long-term capital partner, aligning incentives around durable ownership and disciplined growth rather than short-term outcomes.
Focused on the $1–4M EBITDA Segment of the Lower Middle Market
The $1–4M EBITDA segment of the lower middle market remains highly fragmented and inefficient. Thesis believes disciplined operators, supported by institutional structure and capital, are uniquely positioned to create enduring value within this segment.
The firm is actively partnering with operators who:
-Intend to lead and operate a business full-time
-Value structured partnership and governance
-Seek majority ownership with institutional support
-Are currently under LOI or developing a qualified acquisition pipeline
About Thesis Capital Partners
Thesis Capital Partners is an operator-focused investment firm partnering with executives to acquire and build enduring lower middle market businesses. The firm provides capital, governance, sourcing infrastructure, and long-term strategic support to in-residence operators pursuing disciplined acquisitions.
For more information about the Searcher-in-Residence (SIR) program, please visit www.thesiscapital.com.